tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX
Holding AKTX?
Track your performance easily

Akari Therapeutics (AKTX) Financial Statements

278 Followers

Akari Therapeutics Financial Overview

Akari Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Akari Therapeutics is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 22Jun 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -2.90M$ -7.51M$ -5.57M-$ -5.82M
EBITDA$ -2.90M$ -7.51M$ -5.55M-$ -5.82M
Net Income Common Stockholders$ -2.90M$ -7.56M$ -5.57M-$ -5.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.20M$ 4.20M$ 1.30M$ 13.20M$ 8.15M
Total Assets$ 2.73M$ 5.08M$ 2.77M$ 13.83M$ 11.37M
Total Debt$ 1.00M$ 1.00M$ 0.00$ 0.00$ 0.00
Net Debt$ -1.20M$ -3.20M$ -1.30M$ -13.20M$ -8.15M
Total Liabilities$ 61.62M$ 60.97M$ 58.52M$ 12.04M$ 3.05M
Stockholders Equity$ -6.69M$ -3.70M$ -3.55M$ 1.79M$ 8.33M
Cash Flow-
Free Cash Flow$ -1.49M-$ -4.04M-$ -8.57M
Operating Cash Flow$ -1.49M$ -4.89M$ -4.04M-$ -8.57M
Investing Cash Flow-----
Financing Cash Flow$ -443.00K$ 7.76M$ 1.51M-$ 0.00
Currency in USD

Akari Therapeutics Earnings and Revenue History

Akari Therapeutics Debt to Assets

Akari Therapeutics Cash Flow

Akari Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis